Diabetic foot ulcer. Ulcer of lower limb, not elsewhere classified
Conditions
Interventions
Intervention 1: Intervention group:Wound, washed daily, up to 8 weeks, with iodine 10% produced by Kimia Daroo then a phenytoin compound capsule produced by Caspian Tamin Pharmaceutical Company will
Sponsors
Kermanshah University of Medical Sciences
Eligibility
Sex/Gender
All
Age
18 Years to No maximum
Inclusion criteria
Inclusion criteria: Physician and patient satisfaction Patient alertness (GCS = 15) Age over 18 do not allergic to to iodine and phenytoin No pregnancy Lack of hepatic impairment and renal failure (creatinine level below 2), cancer and osteomyelitis Do not use immunosuppressive and corticosteroid during the last month No smoking Controlled blood sugar Grade I and II foot ulcers according to Meggit-Wagner
Exclusion criteria
Exclusion criteria: Unwillingness to co-operate with a patient or physician Grade III, IV, V foot ulcers according to Meggit-Wagner Amputation Death
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Length and width of diabetic foot ulcer. Timepoint: One, two, three, four, six, eight, ten, and twelve weeks after starting treatment and at the end of the study. Method of measurement: ruler.;Grade of diabetic foot ulcer. Timepoint: One, two, three, four, six, eight, ten, and twelve weeks after starting treatment and at the end of the study. Method of measurement: Wagner ,Pedis and Beta johnson scale.;Infection of diabetic foot ulcer. Timepoint: One, two, three, four, six, eight, ten, and twelve weeks after starting treatment and at the end of the study. Method of measurement: Pedis scale. | — |
Countries
Iran (Islamic Republic of)
Contacts
Public ContactSomayeh Mahdavikian
Kermanshah University of Medical Sciences
Outcome results
None listed